Business
BioSpectrum Asia
FibroGen sells China biz to AstraZeneca for $160 M
FibroGen, Inc. has announced the sale of its China subsidiary to AstraZeneca for approximately $160 million.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Call for collective action to address rising global burden of chronic diseases
The global pharmaceutical industry has issued a \"Call to Action\" urging collective action across the globe to tackle the rise of non-communicable diseases (NCDs) such as cancer, diabetes, cardiovascular disease, lung disease, mental health, and neurological disorders.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Samsung invests $10 M in US-based C2N Diagnostics to strengthen brain healthcare
US-based C2N Diagnostics, LLC, a specialty diagnostics company with a vision to bring Clarity Through Innovation, has announced a $10 million investment from Korea's Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment Corporation.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Trump's tariff war threatens to disrupt pharma supply chain
After pulling US funding from the World Health Organisation (WHO), the US President Donald Trump has now announced a 25 per cent tariff on pharmaceutical imports. With countries like India and China being major suppliers to the U.S. market, this move raises serious concerns about the future of drug prices, supply chains, etc. Let's analyse how this could impact the global pharmaceutical industry.
4 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
GE HealthCare names new president and CEO for China biz
GE HealthCare (GEHC), a leading global healthcare solutions provider, has announced that Yihao Zhang, president and Chief Executive Officer (CEO), China, will retire from the company effective July 1, 2025. Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare's new president and CEO, China, is joining the company on April 1, 2025, ahead of leading the region starting July 1 following Yihao's departure.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Indaptus Therapeutics extends patent portfolio in China, Japan, and Israel
US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its Decoy platform.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Indonesia and Saudi Arabia sign MoU to strengthen human resources within healthcare sector
Indonesian Health Minister Budi Gunadi Sadikin and Saudi Arabian Health Minister Fahd Abdulrahman Al-Jalajel have formalised a Memorandum of Understanding (MoU) aimed at enhancing human resource (HR) capacity of the healthcare sector through exchanges and training, as well as facilitating the exchange of digital vaccine certificates.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Vydehi Institute of Medical Sciences and Research Centre in India to expand access to robotic-assisted surgery
Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, a leading institution in multi-specialty tertiary care in India, has joined hands with Intuitive, a global technology leader in minimally invasive care and the pioneer of roboticassisted surgery (RAS), to introduce resident surgeons to robotic-assisted surgical technology through the Intuitive Robotic Onboarding Programme and Education (I-ROPE).
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Australia approves first and only treatment for chronic hypoparathyroidism
Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has received the registration of YORVIPATH (palopegteriparatide) by the Therapeutic Goods Administration (TGA), for the treatment of chronic hypoparathyroidism in adults.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Bruker introduces X4 POSEIDON advanced X-ray microscope for scientific applications
American manufacturer of scientific instruments Bruker Corporation has announced the launch of the new X4 POSEIDON, a high-performance 3D X-ray microscope (XRM) using micro Computed Tomography (microCT).
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Sun Pharma buys Checkpoint Therapeutics for $255 M
India-based Sun Pharmaceutical Industries Limited and US-based Checkpoint Therapeutics, Inc. have entered into an agreement by which Sun Pharma will acquire Checkpoint, an immunotherapy and targeted oncology company.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
"ADCS have already become a mainstay treatment option across a variety of both hematologic and solid cancers"
The resurgence of antibody-drug conjugates (ADCs) in cancer therapy signifies a shift towards targeted, highly effective treatments, leveraging the power of monoclonal antibodies to deliver potent cytotoxic payloads directly to cancer cells, minimising harm to healthy tissues.
5 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Lunit expands partnership with Saudi Arabia's largest medical group to deploy AI chest X-ray solution
South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has announced a second agreement with Cloud Solutions, a subsidiary of Dr. Sulaiman AI Habib Medical Group (HMG), Saudi Arabia's largest medical organisation.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Parse Biosciences plans to release single cell chromatin accessibility products
The US-based Parse Biosciences, the leader in accessible and scalable single cell sequencing, has affirmed plans to proceed with development and future release of their Evercode single cell chromatin products.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
PerkinElmer acquires Project Farma to expand services for life sciences industry
PerkinElmer, a global leader in analytical solutions and specialised services for biopharma, applied and food markets, has announced the acquisition of Project Farma, a subsidiary of Precision for Medicine.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Astellas and Yaskawa to establish joint venture in Japan focused on cell therapy manufacturing
Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement to establish a joint venture for the development of a cell therapy product manufacturing platform utilising the dual-arm robot 'Maholo'.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
India builds AI-powered model to improve blood sugar predictions for diabetes management
A research team at National Institute of Technology (NIT) Rourkela, India has developed a new artificial intelligence (AI)driven approach to improve blood sugar predictions for people with diabetes.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Singapore announces expansion of healthcare capacity
The Ministry of Health (MOH) in Singapore plans to continue to transform and strengthen its healthcare workforce, in tandem with capacity expansion.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Thailand designs exoskeleton wheelchair to aid mobility
Thailand's Chulalongkorn University has introduced the Exoskeleton Wheelchair, an innovative robotic suit designed to help people with disabilities stand, walk, and move more independently.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
"Biggest challenge in running a chronic Hepatitis B trial is often patient recruitment"
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released its latest disease report: Hepatitis B - Global Clinical Trial Landscape (2025) in March 2025.
5 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Callio Therapeutics launches with $187 M Series A round to advance multi-payload ADC platform
Callio Therapeutics, a Singapore and US-based biotechnology startup focused on realising the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, has announced its launch with the closing of a $187 million Series A financing round.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
PolyU and Peking University explore collaboration in medical technology in China
The Hong Kong Polytechnic University (PolyU) and Peking University Health Science Center (Peking University) have signed a Memorandum of Understanding (MoU) to explore collaboration in the field of medical technology, including joint research and faculty and student exchanges.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Insilico Medicine secures $110 M Series E financing to advance Al-driven drug discovery innovation
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery startup headquartered in Hong Kong, has successfully secured a $110 million Series E financing led by a private equity fund of Value Partners Group, one of Asia's largest independent asset management firms, with strong participation from industry- and technology-focused new investors, as well as continued support from global existing backers.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Docquity introduces AI-powered medical resource platform in Indonesia
Docquity, a leading healthtech company in Southeast Asia, and Rumah Sakit Umum Daerah (RSUD) Umar Wirahadikusumah Sumedang, a regional hospital in West Java, Indonesia, have announced a partnership to integrate Dx, Docquity's artificial intelligence (AI)-powered medical resource platform, into the hospital's medical reference system.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
"Encephalitis is associated with significant costs to individuals and society, due to its high morbidity and mortality"
World Health Organization (WHO) and United Kingdom-headquartered Encephalitis International launched a critical Technical Brief on Encephalitis in London on February 20 as World Encephalitis Day celebrated on February 22 every year.
2 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Advancing Green Pharmaceuticals: Sustainable Biomanufacturing Practices Across APAC
The pharmaceutical industry is at a critical juncture, urgently needing to transform towards sustainability to reduce its environmental footprint.
7 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
"AI will shift the focus of healthcare professionals toward higher-value tasks like clinical decision-making"
Australian AI-powered medical imaging company, Harrison.ai, has secured $112 million in Series C funding to accelerate product development, expand clinical partnerships, and scale its global presence.
4 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
CDMOS Clean Up Act: Environmental Responsibility
Sustainability is no longer a buzzword in the background, but has become critical as the pharmaceutical industry faces evolving regulations and growing environmental concerns.
10+ min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Boehringer Ingelheim enhances biopharma contract manufacturing services in China
Boehringer Ingelheim's biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a regulatory reform promoting segmented manufacturing of biological products by the local authorities.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Healing an Ailing MedTech Talent Ecosystem
The Asia-Pacific (APAC) region represents a critical landscape for the future of medical technology. However, a thriving medical technology sector needs people skilled in engineering, product development and manufacturing. With advances in artificial intelligence (AI) and robotic surgeries driving a big transformation and creating new opportunities, it is also deepening the skills gap many workers face. Let's take a closer look at these gaps and the solutions that are emerging to address those gaps.
7 min |